Biology subjects

Moliere, A.

Publications and source records attributed to Moliere, A..

5 recordsLinked to original sources

bioRxiv2026

Systemic control and inter-organ communication of ovarian aging

Whether ovarian aging is intrinsic and unidirectional or dynamically regulated by systemic context remains an open question for fertility and women's healthspan. To address it, we developed a mouse ovarian transcriptomic aging clock (OvaAge) and applied it, together with published transcriptomic, epigenetic and pathway-resolved DNA methylation (PathAge) clocks, multi-omic analyses and reproductive outcomes, to new reciprocal heterochronic ovary transplantation and parabiosis experiments. Ovarian molecular age shifted in both directions: aged ovaries became younger in young hosts and young ovaries became older in aged hosts, and in each case the shift was partial across transcriptomic, epigenetic and pathway-resolved measures. Ovaries from 13-month-old C57BL/6J donors supported full-term pregnancies and live births at 17-18 months of age when transplanted into young hosts, but not when transplanted into old hosts, and young ovaries supported live births in 17-18-month-old recipients. Donor ovary age altered the transcriptomic age of the uterus in both directions, while young ovaries also lowered the transcriptomic age of aged liver and brain, identifying the ovary as an active node within an inter-organ aging network. Across unilateral and bilateral transplantation and parabiosis, an older environment increased inflammatory gene expression in the ovary, whereas a younger environment reduced it and increased mitochondrial and biosynthetic programs. Integration of methylation, expression and cell-type markers linked these changes to declining oocyte-associated programs and an expanding stromal compartment enriched for multinucleated giant cells (MNGCs). MNGC-rich regions formed a reversibly remodeled, focally aged niche with distinct spatial metabolic features, and a related macrophage expression signature was detected in human ovaries. Together, these findings identify ovarian aging as a modular, bidirectionally plastic process that is regulated by the systemic environment and point to tractable intervention points.

systems biology↗

bioRxiv2026

Old worms, new tricks: dynamical instability explains late-life rejuvenation in C. elegans

How is it possible to double the lifespan of an organism already close to death? Many biological theories of aging fail to explain this phenomenon. At the Physics of Aging workshop, we presented and discussed late-life lifespan extension in Caenorhabditis elegans to illustrate how a simple stochastic dynamical systems model can account for dramatic geriatric interventions. We build on a Langevin-type instability framework in which aging is a manifestation of dynamical instability-a scenario where stochastic fluctuations amplify over time, driving the system toward a failure thresh-old at which death occurs as a first-passage event. The instability rate (equivalently, the inverse of the mortality-rate doubling time) quantifies the speed of this divergence: a larger means faster exponential growth of z, a steeper Gompertz slope, and a shorter lifespan. The failure threshold zmax{approx} /g, where g is the strength of nonlinear feedback, marks the point beyond which the system diverges irreversibly--physiologically, the saturation of metabolic and regulatory capacity. Within this dynamical-systems framework, auxin-induced degradation of the insulin/IGF-1 receptor DAF-2 in very old animals is naturally interpreted as a late shift in stability parameters that nearly doubles remaining lifespan without resetting accumulated structural damage. This interpretation reconciles the persistence of many senescent pathologies with restored proteostasis and stress resilience, and it shows that targeting the dynamical instability of the regulatory network-rather than reversing damage--can strongly reshape survival trajectories in unstable animals. More broadly, our work exemplifies how physics-inspired low-dimensional stochastic models can capture key features of aging, and we hope it will inspire more collaborations between biologists and physicists to work on late-life interventions.

biochemistry↗

bioRxiv2025

Multi-tissue spatial transcriptomics reveals biological age hotspots in mouse and human aging

Aging proceeds heterogeneously across tissues, yet how biological age varies within the spatial architecture of individual organs remains poorly understood. Here, we introduce stAge, a framework that quantifies localized transcriptomic age (tAge) from spatial transcriptomics data in mouse and human samples during natural aging and in response to injury, infection, neurodegeneration, and cancer. stAge captures age differences among samples and provides a single multi-tissue model for assessing aging within and across organs. Across tissues and conditions, stAge uncovers robust spatial gradients of biological age and shows that injury and neurodegeneration induce pronounced age acceleration, with stronger responses in older organisms and partial normalization during recovery. With advancing age, tissues develop pronounced hotspots of accelerated aging and coldspots of preserved resilience. Hotspots are enriched for metabolic and immune aging signatures, whereas chromatin-related signatures are associated with coldspots. These findings show that aging is spatially structured within tissues and lay a foundation for developing spatially targeted rejuvenation strategies.

bioinformatics↗

bioRxiv2024

Transcriptomic Hallmarks of Mortality Reveal Universal and Specific Mechanisms of Aging, Chronic Disease, and Rejuvenation

Health is strongly affected by aging and lifespan-modulating interventions, but the molecular mechanisms of mortality regulation remain unclear. Here, we conducted an RNA-seq analysis of mice subjected to 20 compound treatments in the Interventions Testing Program (ITP). By integrating it with the data from over 4,000 rodent tissues representing aging and responses to genetic, pharmacological, and dietary interventions with established survival data, we developed robust multi-tissue transcriptomic biomarkers of mortality, capable of quantifying aging and change in lifespan in both short-lived and long-lived models. These tools were further extended to single-cell and human data, demonstrating common mechanisms of molecular aging across cell types and species. Via a network analysis, we identified and annotated 26 co-regulated modules of aging and longevity across tissues, and developed interpretable module-specific clocks that capture aging- and mortality-associated phenotypes of functional components, including, among others, inflammatory response, mitochondrial function, lipid metabolism, and extracellular matrix organization. These tools captured and characterized acceleration of biological age induced by progeria models and chronic diseases in rodents and humans. They also revealed rejuvenation induced by heterochronic parabiosis, early embryogenesis, and cellular reprogramming, highlighting universal signatures of mortality, shared across models of rejuvenation and age-related disease. They included Cdkn1a and Lgals3, whose human plasma levels further demonstrated a strong association with all-cause mortality, disease incidence and risk factors, such as obesity and hypertension. Overall, this study uncovers molecular hallmarks of mammalian mortality shared across organs, cell types, species and models of disease and rejuvenation, exposing fundamental mechanisms of aging and longevity.

systems biology↗

bioRxiv2018

A well-controlled BioID design for endogenous bait proteins.

The CRISPR/Cas9 revolution is profoundly changing the way life sciences technologies are used. Many assays now rely on engineered clonal cell lines to eliminate overexpression of bait proteins. Control cell lines are typically non-engineered cells or engineered clones implying a considerable risk for artefacts because of clonal variation. Genome engineering can also transform BioID, a proximity labelling method that relies on fusing a bait protein to a promiscuous biotin ligase, BirA*, resulting in the tagging of vicinal proteins. We here propose an innovative design to enable BioID for endogenous proteins wherein we introduce a T2A-BirA* module at the C-terminus of endogenous p53 by genome engineering, leading to bi-cistronic expression of both p53 and BirA* under control of the endogenous promoter. By targeting a Cas9-cytidine deaminase base editor to the T2A auto-cleavage site, we can efficiently derive an isogenic population expressing a functional p53-BirA* fusion protein. Using quantitative proteomics we show significant benefits over classical ectopic expression of p53-BirA*, and we provide a first well-controlled view on the proximal proteins of endogenous p53 in colon carcinoma cells. This novel application for base editors expands the CRISPR/Cas9 toolbox and can be a valuable addition for synthetic biology.\n\nO_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=142 SRC=\"FIGDIR/small/427807v2_ufig1.gif\" ALT=\"Figure 1\">\nView larger version (20K):\norg.highwire.dtl.DTLVardef@404da1org.highwire.dtl.DTLVardef@1a8af36org.highwire.dtl.DTLVardef@18741a6org.highwire.dtl.DTLVardef@e73ab3_HPS_FORMAT_FIGEXP M_FIG C_FIG

biochemistry↗